Gsk Plc ADR
(GSK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | BMY | VRTX | ||
| Company | Gsk Plc ADR | Bristol-Myers Squibb Company | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 59.29 | 60.00 | 459.69 | ||
| High | 60.37 | 62.05 | 478.28 | ||
| Low | 59.25 | 59.77 | 459.00 | ||
| Latest | 60.23 | 61.99 | 477.92 | ||
| Change | +1.06 | +2.47 | +19.11 | ||
| % Change | +1.79% | +4.15% | +4.17% | ||
| Volume | 8,149,100 | 17,117,600 | 1,621,600 | ||
| 20-Day Average Volume | 6,091,825 | 13,480,380 | 1,473,325 | ||
| Previous Close | 59.17 | 59.52 | 458.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.41 | 55.99 | 463.36 | ||
| 20-Day Raw Stochastic | 98.90% | 99.29% | 87.36% | ||
| 20-Day Relative Strength | 79.49 | 73.64 | 57.55 | ||
| Weighted Alpha | +81.49 | +23.68 | +7.98 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.72% since 01/30/26 | +12.61% since 01/30/26 | +1.71% since 01/30/26 | ||
| Low | 52.13 on 02/02/26 | 54.96 on 02/02/26 | 457.74 on 02/05/26 | ||
| High | 60.37 on 02/06/26 | 62.05 on 02/06/26 | 478.72 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +19.13% since 01/06/26 | +13.91% since 01/06/26 | +2.04% since 01/06/26 | ||
| Low | 47.62 on 01/20/26 | 53.54 on 01/21/26 | 429.00 on 01/20/26 | ||
| High | 60.37 on 02/06/26 | 62.05 on 02/06/26 | 487.52 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +27.88% since 11/06/25 | +32.94% since 11/06/25 | +14.82% since 11/06/25 | ||
| Low | 45.81 on 11/20/25 | 45.26 on 11/20/25 | 406.67 on 11/07/25 | ||
| High | 60.37 on 02/06/26 | 62.05 on 02/06/26 | 487.52 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +63.89% since 08/06/25 | +38.31% since 08/06/25 | +23.93% since 08/06/25 | ||
| Low | 37.07 on 08/07/25 | 42.52 on 10/29/25 | 362.50 on 08/11/25 | ||
| High | 60.37 on 02/06/26 | 62.05 on 02/06/26 | 487.52 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 122,773,192 | 126,196,336 | 121,257,392 | ||
| Shares Outstanding, K | 2,038,406 | 2,035,753 | 253,719 | ||
| Annual Sales | 40,095,390,000 | 48,300,000,000 | 11,020,100,000 | ||
| Annual Net Income | 3,290,590,000 | -8,948,000,000 | -535,600,000 | ||
| Last Quarter Sales | 11,520,500,000 | 12,222,000,000 | 3,076,400,000 | ||
| Last Quarter Net Income | 2,713,320,000 | 2,201,000,000 | 1,082,900,000 | ||
| 60-Month Beta | 0.46 | 0.29 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 02/04/26 | 1.26 on 02/05/26 | 4.80 on 11/03/25 | ||
| Latest Earnings Date | 04/29/26 | 04/23/26 | 02/12/26 | ||
| Most Recent Dividend | 0.426 on 11/14/25 | 0.630 on 01/02/26 | N/A | ||
| Next Ex-Dividends Date | 02/20/26 | 01/02/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 13.09 | 9.68 | 29.97 | ||